期刊文献+

PARP-1与HMGA2在乳腺癌分子分型中的表达及临床意义

Expressions of PARP-1 and HMGA2 in Different Molecular Subtypes of Breast Cancer and Their Clinical Significance
下载PDF
导出
摘要 【目的】通过免疫组化法实验观察PARP‐1和 HMGA2在乳腺癌不同分子分型中的表达,探讨其在乳腺癌中表达的意义及其与临床特点的相关性。【方法】采用免疫组化法检测240例乳腺癌术后肿瘤标本和60例乳腺良性肿瘤组织中PARP‐1与 HMGA2蛋白的表达情况。分析 PARP‐1和 HMGA2在不同分子类型乳腺癌组织中的表达差异;分析两者在不同分子类型表达的相关性及其与原发肿瘤直径、腋窝淋巴结转移等病理特征相关性。【结果】在乳腺癌中 PARP‐1阳性表达率为65.4%显著高于癌旁组织中的22.4%;HMGA2阳性表达率为58.8%高于癌旁组织中的36.4%,PARP‐1及 HMGA2在乳腺癌各分子分型中的阳性表达与腋窝淋巴结转移情况具有相关性( P <0.05),HMGA2的阳性表达在luminal A型及luminal B型中与原发肿瘤大小存在相关性( P <0.05),而在 H ER‐2过表达型及三阴性乳腺癌中不存在相关性( P >0.05)。【结论】PARP‐1与HMGA2在乳腺癌的浸润、转移过程中相互作用,是反映乳腺癌进展的生物学指标。PARP‐1与HMGA2高表达的患者易发生淋巴结转移,预后不良。 [Objective]To explore the expressions of PARP‐1 and HMGA2 in different molecular subtypes of breast cancer and discuss their clinical significance .[Methods] The tissues were collected from 240 cases of breast cancer with complete information and 60 normal cases with a distance of at least 5 cm from tumor .The protein expressions of PARP‐1 and HMGA2 were detected by S‐P immunohistochemistry .[Results] The posi‐tive expression rate of PARP‐1 was significantly higher in breast cancer (65 .4% ) than that in paracancerous normal tissues (22 .4% ) .And the positive expression rate of PARP‐1 in breast cancer (58 .8% ) were higher than that in paracancerous normal tissues (36 .4% ) .Both were strongly correlated with lymph node metastasis ( P 〈0 .05) .In luminal A and luminal B ,HMGA2 was correlated with primary tumor size ,but not HER‐2 and Basal‐like .[Conclusion] The expressions of PARP‐1 and HMGA2 play cooperative roles in the infiltration and metastasis of breast cancer so that both serve as important biological parameters for judging the progres‐sion of breast cancer .Patients with high expressions of PARP‐1 and HMGA2 are susceptible to lymph node metastasis and a poor postoperative prognosis .
出处 《医学临床研究》 CAS 2015年第4期691-695,共5页 Journal of Clinical Research
关键词 聚ADP核糖聚合酶类 HMGA2蛋白 淋巴转移 乳腺肿瘤/病理学 Poly(ADP-ribose) Polymerases HMGA2 Protein Lymphatic Metastasis Breast Neoplasms/PA
  • 相关文献

参考文献15

  • 1徐兵河.乳腺癌预防和治疗热点解析[J].医学研究杂志,2012,41(8):2-4. 被引量:8
  • 2Lee Kraus W, Hottiger MO. PARP-1 and gene regulation: Progress and puzzles[J]. Molecular Aspects of Medicine , 2013, 34(6).,1109-1123.
  • 3谭丽,谭获,魏小平,杨通.肝癌组织中HMGA2蛋白、mRNA表达变化及意义[J].山东医药,2012,52(22):18-21. 被引量:1
  • 4Hu Z, Fan C, Oh DS, et al. The Molecular Portraits Of Breast Tumors Are Conserved Across Microarray Platforms[J]. BMC Genomics, 2006, 7:96(6) :96.
  • 5LA C. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study[J]. JAMA, 2006, 295 (21) .. 2492-2502.
  • 6杨后圃,王殊.转化医学助力21世纪的乳腺癌研究[J].中华乳腺病杂志(电子版),2014,8(1):9-12. 被引量:4
  • 7Johnson N,Shapiro GI. Chemotherapy-induced p53-depend- ent and-independent DNA damage responses are enhanced by poly (ADP-ribose) polymerase (PARP) inhibition in BRCA- proficient cancer eells[J]. Cell Cycle, 2012,11 (3) : 432-433.
  • 8Tan [J, Thusult S, Caja L, et al . Regulation of Transcription Factor Twist Expression by the DNA Architectural Protein High Mohility Group A2 during Epithelial-to-Mesenchymal Transition [J]. J Biol Chem, 2012,287(10) :7134-7145.
  • 9袁波,李刚强,蔡珍福,凌建新,周玉坤.胆管癌组织中HMGA2的表达变化及意义[J].山东医药,2013,53(19):18-20. 被引量:2
  • 10PD, TH, JL, et al . PARP-1 expression in breast cancer in- cluding BRCAl-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy. [J]. Breast Cancer Res Treat, 2011, 127(3) :861-869.

二级参考文献53

  • 1<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 2孟洁,郎荣刚,范宇,付丽.年轻乳腺癌患者的病理学和生物学特征及其与预后的关系[J].中华肿瘤杂志,2007,29(4):284-288. 被引量:29
  • 3Grigioni WF, DErrico A, Bacci F, et al. Primary liver neoplasms: evaluation of proliferative index using MoAb Ki67 [ J ]. J Pathol, 1989,158( 1 ) :23-29.
  • 4Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function [ J ]. Gene, 2001,277 ( 1-2 ) : 63-81.
  • 5Fusco A, Fedele M. Roles of HMGA proteins in cancer[ J]. Nat Rev Cancer, 2007,7(12) :899-910.
  • 6Hock R, Furusawa T, Ueda T, et al. HMG chromosomal proteins in development and disease[ J ]. Trends Cell Biol, 2007,17 (2) : 72-79.
  • 7Godley LA. HMGA2 levels in CML: reflective of miRNA gene reg- ulation in a hematopoietic tumor [ J ]. Leuk Lymphoma, 2007,48 (10) :1898-1899.
  • 8Nyquist KB, Panagopoulos I, Thorsen J, et al. ( 12 ; 13 ) ( q14; q31 ) leading to HMGA2 upregulation in acute myeloid leukaemia [J]. Br J Haematol, 2012,157(6) :769-771.
  • 9Motoyama K, Inoue H, Nakamura Y, et al. Clinical significance of high mobility group A2 in human gastric cancer and ils relationship to let-7 microRNA family [ J ]. Clin Cancer Res, 2008,14 ( 8 ) :2334-2340.
  • 10Huang ML, Chen CC, Chang LC. Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorec- tal cancer J. Int J Colorectal Dis, 2009,24( 11 ) :1281-1286.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部